极早产儿存活阈值处的产科干预:基于复苏计划的意向性治疗分析
当计划复苏时,孕妇更可能接受产前糖皮质激素、硫酸镁、宫缩抑制剂和B族链球菌预防,且剖宫产率更高(P<.05)。联合干预使22周(OR 11.33, 95%CI 1.405-91.4)和23周(OR 15.5, 95%CI 3.747-64.11)存活至NICU出院几率增加;单胎中剖宫产与阴道分娩的存活几率无差异(OR 1.0, 95%CI 0.59-1.8, P=.912)。结论支持在计划复苏的23周分娩时采用以新生儿为导向的产科干预,22周因样本量小未能证实获益。
要点
- 计划复苏时孕妇更可能接受产前激素、硫酸镁、宫缩抑制剂和GBS预防(P<.05)。
- 联合干预增加22周和23周存活至NICU出院的几率(P<.05)。
- 单胎中剖宫产与阴道分娩的存活几率无差异(OR 1.0, 95%CI 0.59-1.8, P=.912)。
核心结论
- 在计划产后复苏的22和23周妊娠中,孕妇更可能接受产前糖皮质激素、硫酸镁和抗生素,该组合在23周带来生存获益,但22周因样本量小未能证实。
主要发现
- 计划复苏时,无论入院孕周,孕妇更可能接受所有常规产科干预(产前激素、硫酸镁神经保护、宫缩抑制剂、GBS预防),且更可能剖宫产(P<.05)。
- 联合使用产前激素、硫酸镁、宫缩抑制剂和GBS预防时,22周出生新生儿存活至NICU出院的OR为11.33(95%CI 1.405-91.4),23周为15.5(95%CI 3.747-64.11),P<.05。
- 单胎中,剖宫产与阴道分娩相比存活至NICU出院的OR为1.0(95%CI 0.59-1.8),P=.912,调整额外干预、体重、性别和孕周后仍无改善。
关键数值与推荐
- 22周联合干预存活至NICU出院OR 11.33(95%CI 1.405-91.4)。
- 23周联合干预存活至NICU出院OR 15.5(95%CI 3.747-64.11)。
- 单胎剖宫产vs阴道分娩存活OR 1.0(95%CI 0.59-1.8, P=.912)。
临床怎么用
- 在23周分娩且计划复苏时,可考虑使用产前糖皮质激素、硫酸镁、宫缩抑制剂和GBS预防以改善新生儿存活。
- 22周计划复苏时,产科干预的生存获益尚未证实,需个体化决策并进一步研究。
- 单胎22-24周分娩时,剖宫产未显示较阴道分娩提高存活至NICU出院的几率。
局限性
- 回顾性研究设计。
- 22周亚组样本量小,未能证实生存获益。
- 多胎妊娠仅作为1例妊娠计入干预分析,但排除于生存分析。
- 已知畸形或数据缺失者被排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite medical advances in the care of extremely preterm neonates and growing acceptance of resuscitation at 23 and even 22 weeks gestation, controversy remains concerning the use of antepartum obstetric intervention s that are intended to improve outcomes in the setting of anticipated extremely preterm birth. In the absence of demonstrated benefit at <23 weeks gestation and with uncertain benefit at 23 weeks gestation, previous obstetric committee opinions have advised against their use at these gestational ages. OBJECTIVE: The purpose of this study was to review the use of obstetric intervention s at the threshold of viability based on neonatal resuscitation plan and to review the odds of survival to neonatal intensive care unit discharge based on use of obstetric intervention s with adjustment for neonatal factors. STUDY DESIGN: This retrospective study of 6 study centers reviewed pregnant patients who were admitted between 22+0/7 and 24+6/7 weeks gestation facing delivery from 2011-2015. Patients with known anomalies or missing data were excluded. Records were reviewed for demographics, resuscitation plan, and obstetric intervention s. Mode of delivery, delivery room care, and final infant dispositions were recorded. Multiple gestations were included as 1 pregnancy in regard to the use of obstetric intervention s and were excluded from survival analysis. RESULTS: Four hundred seventy-eight mothers met the inclusion criteria. When resuscitation was planned, mothers were more likely to receive all conventional obstetric intervention s (antenatal steroids, magnesium sulfate for neuroprotection, tocolytics, and Group Beta Streptococcus prophylaxis), regardless of gestational age at admission, and were more likely to be delivered by cesarean section (P<.05). Analyzed as a group, when antenatal steroids, magnesium sulfate, tocolytics and Group Beta Streptococcus prophylaxis were administered, the odds of survival to neonatal intensive care unit discharge increased for newborn infants who were born at 22 (odds ratio, 11.33; 95% confidence interval, 1.405-91.4) and 23 weeks gestation (odds ratio, 15.5; 95% confidence interval, 3.747-64.11; P<.05). In singletons, the odds of survival to neonatal intensive care unit discharge was not improved by cesarean delivery vs vaginal delivery, even after adjustment for the use of additional interventions, weight, gender, and gestational age (odds ratio, 1.0; 95% confidence interval, 0.59-1.8; P=.912). CONCLUSION: In this study, when postnatal resuscitation was planned at 22 and 23 weeks gestation, women were more likely to receive antenatal steroids, magnesium sulfate, and antibiotics; provision of this bundle imparted survival benefit at 23 weeks gestation but could not be demonstrated at 22 weeks gestation because of the small sample size. These findings support of neonate-oriented obstetric interventions in the setting of delivery at 23 weeks gestation when resuscitation is planned and further exploration of optimal obstetric care when resuscitation of infants who were born at 22 weeks gestation is anticipated.
引用
- Tonismae TR, Tucker Edmonds B, Bhamidipalli SS, et al. Intention to treat: obstetrical management at the threshold of viability. Am J Obstet Gynecol MFM. 2020. PMID: 33345962. doi:10.1016/j.ajogmf.2020.100096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。